Bronchopulmonary Dysplasia
Respiratory·MeSH: Bronchopulmonary Dysplasia
Prevalence
30.0 / 100K
3 drugs in development·3 companies·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| surfactant | GH Research PLC (GHRS) |
Phase 2(1)
Preclinical(1)
| Drug | Company |
|---|---|
| hcw11-040 | HCW Biologics Inc. (HCWB) |
Compare drugs
Frequently asked questions
How many drugs are in development for Bronchopulmonary Dysplasia?
BioSniper tracks 3 drugs in development for Bronchopulmonary Dysplasia across 3 companies.
How many clinical trials target Bronchopulmonary Dysplasia?
There are 3 clinical trials targeting Bronchopulmonary Dysplasia tracked by BioSniper.
What is the prevalence of Bronchopulmonary Dysplasia?
The estimated prevalence of Bronchopulmonary Dysplasia is approximately 30.0 per 100,000 population.
Deep-dive into Bronchopulmonary Dysplasia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis